Linking glucocorticoid action and hypoxia: a novel mechanism driving an adverse metabolic phenotype?

<p>Obstructive sleep apnoea (OSA) is characterised by repeated cycles of reduced and complete obstruction of air flow occurring in sleep. This can result in decreased oxygen levels (hypoxia). OSA and states of glucocorticoid excess are both associated with metabolic diseases including fatty li...